Eric D. Collins

1.9k total citations
36 papers, 1.5k citations indexed

About

Eric D. Collins is a scholar working on Cellular and Molecular Neuroscience, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, Eric D. Collins has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cellular and Molecular Neuroscience, 12 papers in Public Health, Environmental and Occupational Health and 8 papers in Pharmacology. Recurrent topics in Eric D. Collins's work include Neurotransmitter Receptor Influence on Behavior (18 papers), Opioid Use Disorder Treatment (11 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Eric D. Collins is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (18 papers), Opioid Use Disorder Treatment (11 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Eric D. Collins collaborates with scholars based in United States and Spain. Eric D. Collins's co-authors include Sandra D. Comer, Marian W. Fischman, Richard W. Foltin, Margaret Haney, Amie S. Ward, Herbert D. Kleber, Carl L. Hart, Ellen A. Walker, Robert B. MacArthur and Elie S. Nuwayser and has published in prestigious journals such as JAMA, Biological Psychiatry and The American Journal of Cardiology.

In The Last Decade

Eric D. Collins

36 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric D. Collins United States	23	704	535	402	394	264	36	1.5k
Keith G. Heinzerling United States	25	710 1.0×	352 0.7×	544 1.4×	347 0.9×	223 0.8×	55	1.7k
Myroslava K. Romach Canada	24	387 0.5×	653 1.2×	216 0.5×	305 0.8×	161 0.6×	49	1.7k
Paolo Mannelli United States	28	460 0.7×	579 1.1×	707 1.8×	555 1.4×	273 1.0×	91	2.1k
Lorenzo Somaini Italy	25	397 0.6×	379 0.7×	401 1.0×	265 0.7×	250 0.9×	64	1.6k
George E. Bigelow United States	14	434 0.6×	932 1.7×	601 1.5×	375 1.0×	330 1.3×	16	1.6k
Richard B. Resnick United States	19	564 0.8×	481 0.9×	294 0.7×	301 0.8×	338 1.3×	44	1.6k
Jenny Bearn United Kingdom	21	412 0.6×	508 0.9×	381 0.9×	229 0.6×	120 0.5×	35	1.6k
Gavin Bart United States	20	547 0.8×	797 1.5×	702 1.7×	259 0.7×	287 1.1×	70	1.9k
Lon R. Hays United States	28	1.2k 1.6×	376 0.7×	436 1.1×	594 1.5×	233 0.9×	88	2.3k
Joyce H. Lowinson United States	16	1.0k 1.5×	422 0.8×	412 1.0×	816 2.1×	209 0.8×	34	2.2k

Countries citing papers authored by Eric D. Collins

Since Specialization

Citations

This map shows the geographic impact of Eric D. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric D. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric D. Collins more than expected).

Fields of papers citing papers by Eric D. Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric D. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric D. Collins. The network helps show where Eric D. Collins may publish in the future.

Co-authorship network of co-authors of Eric D. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Eric D. Collins. A scholar is included among the top collaborators of Eric D. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric D. Collins. Eric D. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Collins, Eric D. & Bhuvaneswari Ramachandran. (2017). Power management in a microgrid using Teaching Learning Based Optimization Algorithm. 7 indexed citations

Haney, Margaret, Erik W. Gunderson, Huiping Jiang, Eric D. Collins, & Richard W. Foltin. (2009). Cocaine-Specific Antibodies Blunt the Subjective Effects of Smoked Cocaine in Humans. Biological Psychiatry. 67(1). 59–65. 103 indexed citations

Collins, Eric D., et al.. (2007). The effects of acute pretreatment with high-dose memantine on the cardiovascular and behavioral effects of cocaine in humans.. Experimental and Clinical Psychopharmacology. 15(3). 228–237. 24 indexed citations

Collins, Eric D., Suzanne K. Vosburg, Amie S. Ward, Margaret Haney, & Richard W. Foltin. (2006). Memantine increases cardiovascular but not behavioral effects of cocaine in methadone-maintained humans. Pharmacology Biochemistry and Behavior. 83(1). 47–55. 21 indexed citations

Hart, Carl L., Margaret Haney, Eric D. Collins, Eric Rubin, & Richard W. Foltin. (2006). Smoked cocaine self-administration by humans is not reduced by large gabapentin maintenance doses. Drug and Alcohol Dependence. 86(2-3). 274–277. 27 indexed citations

Comer, Sandra D., Ellen A. Walker, & Eric D. Collins. (2005). Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers. Psychopharmacology. 181(4). 664–675. 76 indexed citations

Collins, Eric D., et al.. (2005). Anesthesia-Assisted vs Buprenorphine- or Clonidine-Assisted Heroin Detoxification and Naltrexone Induction. JAMA. 294(8). 903–903. 86 indexed citations

Haney, Margaret, Carl L. Hart, Eric D. Collins, & Richard W. Foltin. (2005). Smoked cocaine discrimination in humans: Effects of gabapentin. Drug and Alcohol Dependence. 80(1). 53–61. 32 indexed citations

Foltin, Richard W., Amie S. Ward, Eric D. Collins, et al.. (2003). The effects of venlafaxine on the subjective, reinforcing, and cardiovascular effects of cocaine in opioid-dependent and non-opioid-dependent humans.. Experimental and Clinical Psychopharmacology. 11(2). 123–130. 23 indexed citations

10.

Collins, Eric D., Suzanne K. Vosburg, Carl L. Hart, Margaret Haney, & Richard W. Foltin. (2003). Amantadine does not modulate reinforcing, subjective, or cardiovascular effects of cocaine in humans. Pharmacology Biochemistry and Behavior. 76(3-4). 401–407. 13 indexed citations

11.

Comer, Sandra D. & Eric D. Collins. (2002). Self-Administration of Intravenous Buprenorphine and the Buprenorphine/Naloxone Combination by Recently Detoxified Heroin Abusers. Journal of Pharmacology and Experimental Therapeutics. 303(2). 695–703. 81 indexed citations

12.

Comer, Sandra D., et al.. (2002). Depot naltrexone: long-lasting antagonism of the effects of heroin in humans. Psychopharmacology. 159(4). 351–360. 138 indexed citations

13.

Rothenberg, Jami L., Maria A. Sullivan, Sarah Church, et al.. (2002). Behavioral naltrexone therapy. Journal of Substance Abuse Treatment. 23(4). 351–360. 65 indexed citations

14.

Comer, Sandra D., Eric D. Collins, Robert B. MacArthur, & Marian W. Fischman. (1999). Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans. Psychopharmacology. 143(4). 327–338. 94 indexed citations

15.

Suckow, Raymond F., et al.. (1999). Sensitive and selective liquid chromatographic assay of memantine in plasma with fluorescence detection after pre-column derivatization. Journal of Chromatography B Biomedical Sciences and Applications. 729(1-2). 217–224. 62 indexed citations

16.

Haney, Margaret, Eric D. Collins, Amie S. Ward, Richard W. Foltin, & Marian W. Fischman. (1999). Effect of a selective dopamine D 1 agonist (ABT-431) on smoked cocaine self-administration in humans. Psychopharmacology. 143(1). 102–110. 105 indexed citations

17.

Collins, Eric D., Amie S. Ward, David M. McDowell, Richard W. Foltin, & Marian W. Fischman. (1998). The effects of memantine on the subjective, reinforcing and cardiovascular effects of cocaine in humans. Behavioural Pharmacology. 9(7). 587–598. 47 indexed citations

18.

Comer, Sandra D., et al.. (1998). Effects of an alternative reinforcer on intravenous heroin self-administration by humans. European Journal of Pharmacology. 345(1). 13–26. 69 indexed citations

19.

Muskin, Philip R., et al.. (1996). Lorazepam Reduces Cardiac Vagal Modulation in Normal Subjects. Journal of Clinical Psychopharmacology. 16(6). 449–453. 20 indexed citations

20.

Polis, Michael A., Victoria J. Davey, Eric D. Collins, et al.. (1988). The emergency department as part of a successful strategy for increasing adult immunization. Annals of Emergency Medicine. 17(10). 1016–1016. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact